10,194
Total Claims
$1.8M
Drug Cost
972
Beneficiaries
$1,817
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+19%
Cost per patient vs peers
$1,817 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 8,805 claims · $340K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 454 | $519K |
| Sacubitril/Valsartan | 173 | $277K |
| Empagliflozin | 104 | $126K |
| Rivaroxaban | 81 | $111K |
| Evolocumab | 68 | $98K |
| Dronedarone Hcl | 50 | $77K |
| Ranolazine | 183 | $44K |
| Ticagrelor | 29 | $35K |
| Icosapent Ethyl | 60 | $29K |
| Rosuvastatin Calcium | 592 | $27K |
| Metoprolol Succinate | 978 | $24K |
| Alirocumab | 15 | $23K |
| Ezetimibe | 282 | $21K |
| Pitavastatin Calcium | 18 | $14K |
| Atorvastatin Calcium | 767 | $13K |
Prescribing Profile
83
Unique Drugs
$1.0M
Patient Profile
75
Avg Age
64%
Female
1.67
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data